CSL
The Senior Director, SID is a senior leader accountable for strategy and operational delivery of the SID portfolio across the International region, shaping regional brand direction and go-to-market approach. The role oversees positioning for inline CSL Vifor brands and future product launches and coordinates pan-regional marketing alignment across affiliates. The position reports to the Executive Director, IG Portfolio Lead, Commercial Operations International.
Headquarters
Melbourne, Victoria, Australia
Company Size
10001+ employees
Founded
1916
CSL is a leading global biotechnology company dedicated to creating lifesaving medicines. With a portfolio that includes therapies for rare diseases, immune deficiencies, and vaccines for influenza, CSL's mission is rooted in innovation and public health. The organization comprises three distinct businesses: CSL Behring, focused on plasma-derived therapies; CSL Seqirus, specializing in influenza vaccines; and CSL Vifor, addressing iron deficiency and nephrology. Since its founding in 1916, CSL has been committed to ensuring access to essential treatments for patients in over 100 countries.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CSL.
CSL didn’t post a salary, so this is our estimate from similar listings.
Regional Marketing Manager (Central Nervous System and Cardiometabolic) - Established Pharmaceuticals Division - Mexico
Abbott Laboratories
Senior Director Market Access Inline Immunoglobulins (IG)
CSL Behring Australia
Senior Product Marketing Specialist – Digital Markets
Gartner
International Marketing Manager - NUK, Graco
Newell Brands
Senior Business Marketing Manager
Philips
Senior Director Regional Marketing (f/m/d), Oncology
Regeneron Pharmaceuticals